Indraprastha Medical Corporation Ltd
NSE:INDRAMEDCO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Indraprastha Medical Corporation Ltd
NSE:INDRAMEDCO
|
IN |
|
Morozoff Ltd
TSE:2217
|
JP |
Balance Sheet
Balance Sheet Decomposition
Indraprastha Medical Corporation Ltd
Indraprastha Medical Corporation Ltd
Balance Sheet
Indraprastha Medical Corporation Ltd
| Mar-2002 | Mar-2003 | Mar-2004 | Mar-2005 | Mar-2006 | Mar-2007 | Mar-2008 | Mar-2009 | Mar-2010 | Mar-2011 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
56
|
116
|
24
|
63
|
37
|
51
|
21
|
17
|
28
|
8
|
15
|
18
|
20
|
19
|
14
|
19
|
25
|
168
|
203
|
249
|
417
|
523
|
2 244
|
3 218
|
|
| Cash |
56
|
116
|
24
|
63
|
37
|
51
|
21
|
17
|
28
|
8
|
15
|
18
|
20
|
19
|
14
|
19
|
25
|
168
|
203
|
249
|
417
|
523
|
616
|
615
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 628
|
2 603
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
13
|
12
|
17
|
15
|
23
|
9
|
9
|
4
|
6
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
740
|
1 603
|
2 571
|
|
| Total Receivables |
202
|
273
|
362
|
532
|
791
|
864
|
553
|
568
|
664
|
658
|
872
|
945
|
1 044
|
1 014
|
1 241
|
1 184
|
990
|
869
|
911
|
872
|
654
|
750
|
649
|
858
|
|
| Accounts Receivables |
70
|
109
|
190
|
262
|
407
|
384
|
161
|
82
|
70
|
325
|
324
|
525
|
644
|
705
|
848
|
983
|
845
|
762
|
792
|
674
|
434
|
682
|
584
|
755
|
|
| Other Receivables |
133
|
164
|
172
|
269
|
385
|
480
|
392
|
486
|
595
|
333
|
548
|
420
|
400
|
309
|
393
|
201
|
145
|
107
|
119
|
198
|
220
|
68
|
65
|
103
|
|
| Inventory |
45
|
41
|
40
|
83
|
64
|
78
|
95
|
91
|
96
|
97
|
103
|
117
|
124
|
91
|
96
|
100
|
91
|
83
|
121
|
87
|
100
|
85
|
75
|
70
|
|
| Other Current Assets |
35
|
35
|
35
|
35
|
47
|
63
|
96
|
126
|
104
|
164
|
196
|
232
|
281
|
156
|
164
|
277
|
223
|
235
|
180
|
206
|
403
|
134
|
137
|
198
|
|
| Total Current Assets |
338
|
465
|
460
|
712
|
939
|
1 069
|
777
|
819
|
907
|
950
|
1 194
|
1 320
|
1 473
|
1 286
|
1 522
|
1 579
|
1 329
|
1 356
|
1 415
|
1 414
|
1 574
|
2 231
|
3 080
|
4 311
|
|
| PP&E Net |
1 658
|
1 639
|
1 588
|
1 424
|
1 652
|
1 692
|
1 932
|
2 012
|
2 091
|
2 594
|
2 753
|
2 997
|
2 924
|
3 047
|
3 018
|
2 939
|
2 928
|
2 809
|
3 013
|
2 833
|
2 752
|
2 766
|
3 464
|
3 600
|
|
| PP&E Gross |
1 658
|
1 639
|
1 588
|
1 424
|
1 652
|
1 692
|
1 932
|
2 012
|
2 091
|
2 594
|
2 753
|
2 997
|
2 924
|
0
|
3 018
|
2 939
|
2 928
|
2 809
|
3 013
|
2 833
|
2 752
|
2 766
|
3 464
|
3 600
|
|
| Accumulated Depreciation |
460
|
561
|
670
|
920
|
1 047
|
1 163
|
1 321
|
1 505
|
1 669
|
1 707
|
1 921
|
2 039
|
2 287
|
0
|
341
|
625
|
903
|
1 121
|
1 381
|
1 620
|
1 792
|
2 159
|
2 128
|
2 275
|
|
| Intangible Assets |
0
|
0
|
9
|
6
|
3
|
3
|
3
|
2
|
4
|
4
|
6
|
6
|
23
|
20
|
19
|
18
|
12
|
4
|
14
|
34
|
17
|
10
|
11
|
6
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
61
|
56
|
67
|
42
|
47
|
45
|
51
|
55
|
48
|
38
|
274
|
63
|
41
|
23
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
455
|
605
|
549
|
|
| Other Long-Term Assets |
12
|
9
|
6
|
3
|
0
|
0
|
0
|
10
|
36
|
26
|
7
|
2
|
2
|
3
|
0
|
3
|
3
|
0
|
0
|
0
|
0
|
27
|
32
|
27
|
|
| Total Assets |
2 009
N/A
|
2 113
+5%
|
2 064
-2%
|
2 145
+4%
|
2 594
+21%
|
2 765
+7%
|
2 712
-2%
|
2 843
+5%
|
3 038
+7%
|
3 581
+18%
|
4 020
+12%
|
4 381
+9%
|
4 488
+2%
|
4 397
-2%
|
4 605
+5%
|
4 584
0%
|
4 323
-6%
|
4 224
-2%
|
4 490
+6%
|
4 320
-4%
|
4 617
+7%
|
5 551
+20%
|
7 232
+30%
|
8 516
+18%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
100
|
88
|
43
|
87
|
96
|
92
|
130
|
150
|
247
|
361
|
300
|
380
|
643
|
746
|
885
|
721
|
713
|
910
|
1 037
|
918
|
768
|
982
|
1 396
|
1 225
|
|
| Accrued Liabilities |
3
|
4
|
2
|
2
|
6
|
8
|
8
|
8
|
2
|
29
|
56
|
83
|
61
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
150
|
246
|
222
|
150
|
296
|
447
|
648
|
386
|
3
|
40
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
173
|
148
|
215
|
220
|
150
|
50
|
25
|
60
|
60
|
21
|
25
|
28
|
25
|
17
|
22
|
|
| Other Current Liabilities |
284
|
334
|
428
|
488
|
611
|
713
|
495
|
656
|
821
|
569
|
1 013
|
1 063
|
845
|
464
|
523
|
463
|
225
|
268
|
298
|
216
|
139
|
290
|
241
|
540
|
|
| Total Current Liabilities |
386
|
426
|
473
|
577
|
713
|
814
|
633
|
814
|
1 070
|
1 282
|
1 763
|
1 962
|
1 920
|
1 655
|
1 905
|
1 857
|
1 384
|
1 241
|
1 396
|
1 159
|
935
|
1 296
|
1 654
|
1 787
|
|
| Long-Term Debt |
380
|
360
|
161
|
231
|
497
|
536
|
646
|
493
|
293
|
427
|
279
|
297
|
258
|
107
|
25
|
0
|
210
|
150
|
0
|
0
|
25
|
0
|
323
|
305
|
|
| Deferred Income Tax |
204
|
265
|
316
|
253
|
263
|
280
|
293
|
318
|
318
|
307
|
314
|
338
|
355
|
351
|
343
|
307
|
298
|
274
|
203
|
223
|
232
|
200
|
197
|
154
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
71
|
72
|
75
|
84
|
90
|
95
|
112
|
108
|
119
|
213
|
210
|
171
|
261
|
281
|
303
|
|
| Total Liabilities |
970
N/A
|
1 050
+8%
|
950
-10%
|
1 060
+12%
|
1 473
+39%
|
1 630
+11%
|
1 572
-4%
|
1 625
+3%
|
1 681
+3%
|
2 087
+24%
|
2 427
+16%
|
2 671
+10%
|
2 617
-2%
|
2 203
-16%
|
2 368
+7%
|
2 276
-4%
|
2 000
-12%
|
1 783
-11%
|
1 812
+2%
|
1 592
-12%
|
1 363
-14%
|
1 757
+29%
|
2 455
+40%
|
2 549
+4%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
917
|
917
|
917
|
917
|
917
|
917
|
917
|
917
|
917
|
917
|
917
|
917
|
917
|
917
|
917
|
917
|
917
|
917
|
917
|
917
|
917
|
917
|
917
|
917
|
|
| Retained Earnings |
122
|
146
|
197
|
169
|
205
|
218
|
223
|
301
|
440
|
577
|
676
|
793
|
955
|
1 277
|
1 324
|
1 388
|
1 400
|
1 518
|
1 776
|
1 800
|
2 386
|
3 018
|
3 983
|
5 180
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
7
|
5
|
15
|
11
|
48
|
140
|
122
|
130
|
|
| Total Equity |
1 039
N/A
|
1 063
+2%
|
1 114
+5%
|
1 085
-3%
|
1 121
+3%
|
1 134
+1%
|
1 140
+0%
|
1 218
+7%
|
1 357
+11%
|
1 493
+10%
|
1 593
+7%
|
1 710
+7%
|
1 871
+9%
|
2 194
+17%
|
2 238
+2%
|
2 308
+3%
|
2 323
+1%
|
2 440
+5%
|
2 678
+10%
|
2 728
+2%
|
3 254
+19%
|
3 795
+17%
|
4 778
+26%
|
5 967
+25%
|
|
| Total Liabilities & Equity |
2 009
N/A
|
2 113
+5%
|
2 064
-2%
|
2 145
+4%
|
2 594
+21%
|
2 765
+7%
|
2 712
-2%
|
2 843
+5%
|
3 038
+7%
|
3 581
+18%
|
4 020
+12%
|
4 381
+9%
|
4 488
+2%
|
4 397
-2%
|
4 605
+5%
|
4 584
0%
|
4 323
-6%
|
4 224
-2%
|
4 490
+6%
|
4 320
-4%
|
4 617
+7%
|
5 551
+20%
|
7 232
+30%
|
8 516
+18%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
92
|
92
|
92
|
92
|
92
|
92
|
92
|
92
|
92
|
92
|
92
|
92
|
92
|
92
|
92
|
92
|
92
|
92
|
92
|
92
|
92
|
92
|
92
|
92
|
|